Skip to main content

Treating latent tuberculosis with rifampin: is it the cheaper option?

Publication ,  Journal Article
Stout, JE; Holland, DP
Published in: Thorax
July 2010

Duke Scholars

Published In

Thorax

DOI

EISSN

1468-3296

Publication Date

July 2010

Volume

65

Issue

7

Start / End Page

572 / 573

Location

England

Related Subject Headings

  • Rifampin
  • Respiratory System
  • Latent Tuberculosis
  • Humans
  • Health Care Costs
  • Antibiotics, Antitubercular
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Stout, J. E., & Holland, D. P. (2010). Treating latent tuberculosis with rifampin: is it the cheaper option? Thorax, 65(7), 572–573. https://doi.org/10.1136/thx.2010.138685
Stout, Jason E., and David P. Holland. “Treating latent tuberculosis with rifampin: is it the cheaper option?Thorax 65, no. 7 (July 2010): 572–73. https://doi.org/10.1136/thx.2010.138685.
Stout JE, Holland DP. Treating latent tuberculosis with rifampin: is it the cheaper option? Thorax. 2010 Jul;65(7):572–3.
Stout, Jason E., and David P. Holland. “Treating latent tuberculosis with rifampin: is it the cheaper option?Thorax, vol. 65, no. 7, July 2010, pp. 572–73. Pubmed, doi:10.1136/thx.2010.138685.
Stout JE, Holland DP. Treating latent tuberculosis with rifampin: is it the cheaper option? Thorax. 2010 Jul;65(7):572–573.

Published In

Thorax

DOI

EISSN

1468-3296

Publication Date

July 2010

Volume

65

Issue

7

Start / End Page

572 / 573

Location

England

Related Subject Headings

  • Rifampin
  • Respiratory System
  • Latent Tuberculosis
  • Humans
  • Health Care Costs
  • Antibiotics, Antitubercular
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences